News for Biotron Limited (BIT.AX)

Published at

Mar 4, 2025 4:23 AM

by themarketherald.com.au

neutral

neutral

Wrong button: Biotron explains to ASX why possible bankruptcy wasn’t price sensitive

It wasn't just Kalina Power getting told off by Compliance on Tuesday – Biotron also had to run the gauntlet.

BIT.AX

Read more →
Published at

Sep 6, 2024 5:04 AM

by themarketherald.com.au

neutral

neutral

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty.

BIT.AX

Read more →
Published at

Jun 19, 2024 4:35 AM

by themarketherald.com.au

mixed

mixed

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial results.

AT1.AX BITRF BIT.AX

Read more →
Published at

May 4, 2023 4:32 AM

by themarketherald.com.au

positive

positive

Biotron (ASX:BIT) kicks off phase II COVID-19 clinical trial in Thailand

Biotron (ASX:BIT) has kicked off a phase II trial of its lead antiviral drug, BIT225, to treat COVID-19 within three days of the onset of symptoms over seven days of treatment.

BIT.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 24, 2022 8:20 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Guy's got some gold that's 'bigger than Texas', how to protect your shares from a 'platform' collapse, and why the 'tech-led' recession is actually not.

TZLTF TZL.AX TER.AX SYA.AX RBR.AX RAG.AX POD.AX PLL.AX PG1.AX PEN.AX NNG.AX MMM.AX MLYSF M24.AX KNM.AX JAY.AX ICL.AX HRN.AX EZL.AX EWC.AX CRR.AX BML.AX AOU.AX AFL.AX TSL.AX OIL.AX MTH.AX MEB.AX MDBIF MCM.AX LSR.AX KFE.AX IVZ.AX IRI.AX GRV.AX GLV.AX ERL.AX BXN.AX BITRF BIT.AX AX8.AX AVW.AX AUK.AX 99L.AX WSR.AX AUN.AX AQX.AX

Read more →
Published at

Nov 24, 2022 6:39 AM

by stockhead.com.au

mixed

mixed

Closing Bell: RBA tries (and fails) to dampen investor enthusiasm as ASX edges to 6mth high

ASX 200 ends flat today, small cap index falls 0.44% but 7 out of 11 sectors were in the green.

TZLTF TZL.AX TER.AX RBR.AX RAG.AX POD.AX PG1.AX MGV.AX M24.AX LSR.AX JAY.AX ICL.AX HRN.AX EZL.AX EWC.AX CRR.AX AX8.AX XRO.AX WTC.AX TSL.AX STO.AX STG.AX OIL.AX MTH.AX MEB.AX MDBIF MCM.AX KNM.AX KFE.AX IVZ.AX IRI.AX GRV.AX GLV.AX BXN.AX BML.AX BITRF BIT.AX AVW.AX AUK.AX AOU.AX AFL.AX 99L.AX ERS ERL.AX AQX.AX

Read more →
Published at

Nov 24, 2022 12:37 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: These ASX lithium and manganese stocks are thrilling punters on Thursday

The Lodestar Minerals (ASX:LSR) and Auroch Minerals (ASX:AOU) JV have drilled into high grade lithium at the Nepean project.

MEB.AX MDBIF BITRF BIT.AX AMD.AX YRL.AX WSR.AX TSC.AX TER.AX IVZ.AX AX8.AX AUN.AX AOU.AX LSR.AX HRN.AX GLV.AX BXN.AX BCA.AX 99L.AX

Read more →
Published at

Nov 23, 2022 7:50 PM

by stockhead.com.au

mixed

mixed

How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors but could it also do with better PR?

VTG.AX NEU.AX MXC.AX KZA.AX CSL.AX COH.AX BWXXF BWX.AX AT1.AX ADR.AX ADO.AX ZNO.AX ZLD.AX UBI.AX TD1.AX SHL.AX RSH.AX RHT.AX RAC.AX PNV.AX PBP.AX OVN.AX OSX.AX OSL.AX OCC.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX ICS.AX ICR.AX EYE.AX CPH.AX CMP.AX CALZF BXN.AX AMDHF 1ST.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDR.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX IDT.AX HCT.AX GTG.AX GSS.AX GLH.AX FDMDF DXB.AX DVL.AX CYP.AX CKDXF CGS.AX CAN.AX CAJ.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 2, 2022 8:30 PM

by stockhead.com.au

mixed

mixed

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations

Four ASX healthcare stocks have been rated as a ‘Strong Buy' by Morningstar’s consensus of brokers, making them hot tips.

ZNO.AX RHT.AX LBT.AX KZA.AX IUGNF IMU.AX ICR.AX EPN.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 1ST.AX ZLD.AX RAC.AX PNV.AX PBP.AX ONE.AX OIL.AX NXSCF NXS.AX MDR.AX IPDQF IPD.AX IMRNW IMRN IMC.AX GTG.AX GSS.AX GLH.AX FDMDF EYE.AX CYP.AX CALZF BNOEF BNO.AX 4DX.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IMM.AX IHL.AX IDT.AX HCT.AX DXB.AX DVL.AX CPH.AX CMP.AX CKDXF CGS.AX CAN.AX CAJ.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX AT1.AX AMDHF ADR.AX ADO.AX 1AD.AX

Read more →
Published at

Oct 28, 2022 7:53 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO Wrap: Small caps ahead this week, but end Friday lower; WA1 wins the meat tray, up 567% this week

Weekly Small Cap and IPO Wrap: Small caps ahead this week, but end Friday lower; WA1 wins the meat tray, up 567% this week

VRC.AX TPP.AX PPY.AX NWM.AX NWC.AX MBK.AX KEY.AX GPR.AX FTC.AX ELO.AX DSK.AX DEL.AX CXX.AX CODAF CDA.AX CBE.AX WSP.AX WHSPF WBT.AX TTI.AX SIH.AX SEN.AX RAS.AX PHL.AX PGD.AX MKL.AX MEB.AX MDBIF LME.AX IHR.AX ID8.AX ICE.AX GLV.AX FRM.AX DTI.AX BUENF BLU.AX ARV.AX ANL.AX 3DA.AX YI SKN.AX SKF.AX OIL.AX ODA.AX MAY.AX KFE.AX IPDQF IPD.AX ICNOF ICN.AX HT8.AX GGX.AX ERG.AX EMP.AX CSE.AX CLE.AX CFO.AX CFFMF BPH.AX BITRF BIT.AX AVA.AX AQX.AX AO1.AX AJL.AX

Read more →
Published at

Oct 27, 2022 9:20 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

How to trade and profit from volatility, should we worry about low metals inventories, and four key investing principles for long-term success.

TTM.AX TKM.AX RVR.AX OAU.AX MXC.AX MCM.AX ICNOF ICN.AX GTG.AX GBE.AX CAV.AX BTR.AX WBT.AX VPR.AX TMX.AX SMX.AX RXL.AX RNT.AX POL.AX OOK.AX OKR.AX NWM.AX MEM.AX EQR.AX EMD.AX EGH.AX CBE.AX BUENF BPP.AX BOT.AX BLU.AX BITRF BIT.AX ARD.AX AMI.AX AMGRF AMD.AX AMA.AX ALB.AX SIX.AX SI6.AX RNX.AX PGD.AX ORN.AX MCL.AX MAY.AX BWNAF BTH.AX ANL.AX AJL.AX ADR.AX

Read more →
Published at

Oct 27, 2022 9:20 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

How to profit from volatility, should we worry about low metals inventories, and four key investing principles for long-term success.

TTM.AX TKM.AX RVR.AX OAU.AX MXC.AX MCM.AX ICNOF ICN.AX GTG.AX GBE.AX CAV.AX BTR.AX WBT.AX VPR.AX TMX.AX SMX.AX RXL.AX RNT.AX POL.AX OOK.AX OKR.AX NWM.AX MEM.AX EQR.AX EMD.AX EGH.AX CBE.AX BUENF BPP.AX BOT.AX BLU.AX BITRF BIT.AX ARD.AX AMI.AX AMGRF AMD.AX AMA.AX ALB.AX SIX.AX SI6.AX RNX.AX PGD.AX ORN.AX MCL.AX MAY.AX BWNAF BTH.AX ANL.AX AJL.AX ADR.AX

Read more →
Published at

Oct 27, 2022 1:34 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: The spotlight in on lithium, Bevan Slattery, and WA1 (again!) first thing Thursday

Stockhead’s Top 10 at 10, published at ~10.30am, highlights the best (and worst) performing ASX stocks in morning trade using live data.

RNT.AX SI6.AX BWNAF BUENF BLU.AX RXL.AX ROG.AX PGD.AX BPP.AX BITRF BIT.AX AJL.AX

Read more →
Published at

Oct 20, 2022 9:00 PM

by stockhead.com.au

mixed

mixed

Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?

There were 191 ASX IPOs in calendar year 2021, and 15 of them were biotech stocks.But in 2022 there were only 3 biotech listings.

PXSLY PXS.AX PAB.AX OSL.AX MEM.AX ILA.AX GLH.AX CAJ.AX BPH.AX AMDHF AGN.AX ZLD.AX UBI.AX TD1.AX SCU.AX RSH.AX RNO.AX RHY.AX RGS.AX PYC.AX PGC.AX PBP.AX OSX.AX OPT.AX OPT OIL.AX OCC.AX NXSCF NXS.AX NOXOF NOX.AX NC6.AX MXC.AX MEB.AX MDR.AX MDC.AX MDBIF KMLXF IPDQF IPD.AX IMRNW IMRN IMC.AX IHL.AX HXL.AX GTG.AX EYE.AX DVL.AX CPH.AX CKDXF BWXXF BWX.AX BITRF BIT.AX AT1.AX ARUXF ACR.AX 1ST.AX ZNO.AX VTG.AX VLS.AX SOMNF SOM.AX RHT.AX RAC.AX PSQ.AX PNV.AX PCK.AX OVN.AX ONE.AX NYR.AX MX1.AX MVF.AX LBT.AX KZA.AX IVX.AX IUGNF IMU.AX IMM.AX IDT.AX ICR.AX HCT.AX GSS.AX FDMDF DXB.AX CYP.AX CMP.AX CGS.AX CAN.AX CALZF BXN.AX BNOEF BNO.AX ATX.AX ARX.AX AMT.AX ALC.AX ADR.AX ADO.AX ACW.AX 4DX.AX 1AD.AX

Read more →
Published at

Oct 5, 2022 9:30 PM

by stockhead.com.au

mixed

mixed

Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice

Blood clot was top of biotech news this week after researchers revealed new discovery that could prevent it without risk of bleeding.

NOXOF NOX.AX JNJ EX1.AX DJNJ3.BA DJNJ2.BA CGS.AX RCEL PYC.AX PBP.AX OPT.AX OPT OCC.AX NC6.AX MDC.AX KZIA KZA.AX IVX.AX IDT.AX GSS.AX EOFBF EOF.AX DVL.AX CYC.AX CSLN.MX CSLLY CSL.AX CMXHF CKDXF CAN.AX BPH.AX AVH.AX ARX.AX ARUXF AFP.AX ACR.AX 1AD.AX ZLD.AX WFL.AX VTG.AX VLS.AX SPL.AX SCU.AX RNO.AX RGS.AX RAC.AX QURE PXSLY PXS.AX PAB.AX OSL.AX NYR.AX NXSCF NXS.AX MYX.AX MXC.AX MSB.AX MESO MEOBF MEM.AX LGP.AX IUGNF IMU.AX IMRNW IMRN IMMP IMM.AX IMC.AX IHL.AX GTG.AX GENE DXB.AX CYP.AX CPH.AX CGB.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ADO.AX

Read more →